Description

1H-Benzimidazole,5-Chloro-2-[1-[(1-Cyclohexyl-1H-Tetrazol-5-Yl)Methyl]-4-Piperidinyl]-(9Ci) is a sophisticated heterocyclic organic compound featuring a benzimidazole core linked to a piperidinyl-tetrazole moiety, representing a high-value advanced pharmaceutical intermediate. This compound matters for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting complex disease pathways. Pharmaceutical R&D departments and fine chemical manufacturers need this high-purity intermediate to develop next-generation therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the research and synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Tool Compound: Used in pharmacological research as a probe to study specific enzyme or receptor interactions.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses to construct complex molecular architectures with high specificity.
• Contract Manufacturing (CMO): Supplied to contract development and manufacturing organizations (CDMOs) for cGMP production of clinical trial materials.
• Academic Research: Utilized in university and institutional labs for advanced studies in organic chemistry and drug development methodologies.

Basic Information

Item	Details
Product Name	1H-Benzimidazole,5-Chloro-2-[1-[(1-Cyclohexyl-1H-Tetrazol-5-Yl)Methyl]-4-Piperidinyl]-(9Ci)
CAS No.	606082-46-6
Molecular Formula	C20H25ClN8
Molecular Weight	412.92 g/mol
Synonyms	5-Chloro-2-[1-[(1-cyclohexyl-1H-tetrazol-5-yl)methyl]piperidin-4-yl]-1H-benzimidazole; 5-Chloro-2-(1-((1-cyclohexyl-1H-tetrazol-5-yl)methyl)piperidin-4-yl)-1H-benzo[d]imidazole; UNII-8K3G3K8Q2I; 8K3G3K8Q2I; Benzimidazole, 5-chloro-2-[1-[(1-cyclohexyl-1H-tetrazol-5-yl)methyl]-4-piperidinyl]-; SCHEMBL21802127; AOB31117; ZINC000253899308
EINECS	Contact for details

Quality Control

Our 1H-Benzimidazole,5-Chloro-2-[1-[(1-Cyclohexyl-1H-Tetrazol-5-Yl)Methyl]-4-Piperidinyl]-(9Ci) is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data are available upon request, providing full traceability and compliance documentation for your regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep the container sealed to protect this light-sensitive material from moisture and contamination.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%; Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.